Obesity impacts brain metabolism and structure independently of amyloid and tau pathology in healthy elderly.

ABSTRACT:

Aims/hypothesis

Midlife obesity is a risk factor for dementia. We investigated the impact of obesity on brain structure, metabolism, and cerebrospinal fluid (CSF) core Alzheimer's disease (AD) biomarkers in healthy elderly.

Methods

We selected controls from ADNI2 with CSF AD biomarkers and/or fluorodeoxyglucose positron emission tomography (FDG-PET) and 3T-MRI. We measured cortical thickness, FDG uptake, and CSF amyloid beta (Aβ)1-42, p-tau, and t-tau levels. We performed regression analyses between these biomarkers and body mass index (BMI).

Results

We included 201 individuals (mean age 73.5 years, mean BMI 27.4 kg/m²). Higher BMI was related to less cortical thickness and higher metabolism in brain areas typically not involved in AD (family-wise error [FW

SUBMITTER: Pegueroles J 

PROVIDER: S-EPMC7385480 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature